EC
GOSS icon

EcoR1 Capital’s Gossamer Bio GOSS Stock Holding History

EcoR1 Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,195,404
Closed -$10.9M – 58
2024
Q1 		$10.9M Hold
9,195,404
– – 0.27% 44
2023
Q4 		$8.39M Hold
9,195,404
– – 0.22% 35
2023
Q3 		$7.66M Buy
+9,195,404
New +$10.6M 0.26% 36
2022
Q4 		– Sell
-4,160,887
Closed -$49.8M – 70
2022
Q3 		$49.8M Buy
+4,160,887
New +$51.6M 1.47% 15
2021
Q1 		– Sell
-294,221
Closed -$2.85M – 77
2020
Q4 		$2.85M Buy
+294,221
New +$2.9M 0.15% 48
2019
Q3 		– Sell
-772,096
Closed -$15.4M – 40
2019
Q2 		$17.1M Hold
772,096
– – 1.73% 16
2019
Q1 		$16.7M Buy
+772,096
New +$16.1M 1.54% 19

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EcoR1 Capital's GOSS Position: Q2 2024 in Review

EcoR1 Capital sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 9,195,404 shares — an estimated $10.9M sold.

EcoR1 Capital first reported a position in GOSS in Q1 2019 and held it in 7 quarters. The position peaked at $49.8M in Q3 2022. 94 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • EcoR1 Capital reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • EcoR1 Capital sold 9,195,404 Gossamer Bio shares in Q2 2024, an estimated $10.9M.
  • EcoR1 Capital first reported a position in Gossamer Bio in Q1 2019 and held it in 7 quarters.
  • EcoR1 Capital's Gossamer Bio position peaked at $49.8M in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on EcoR1 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.